Chengda Pharmaceuticals Co.,Ltd.’s Net Profit Rose 27.9% in First Half of 2022

Chengda Pharmaceuticals Co.,Ltd. (诚达药业股份有限公司) (301201.SZ) reported a net profit of 65.1 million yuan in the first half of 2022, up 27.9% year-on-year.

Meanwhile, the company posted 217.2 million yuan in revenue, up 11.3% year-on-year.

At the end of the reporting period, it had 2.3 billion yuan in total assets and 82.9 million yuan in total liabilities, with a liability-to-asset ratio of 3.7%.